Home European Commission approves EYLEA Injection for treatment of visual impairment due to DME
 

Keywords :   


European Commission approves EYLEA Injection for treatment of visual impairment due to DME

2014-08-11 12:16:33| Biotech - Topix.net

Regeneron Pharmaceuticals, Inc. today announced that EYLEA Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema .

Tags: to due treatment visual

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »